Rahlfs Capital, LLC Merck & Co., Inc. Transaction History
Rahlfs Capital, LLC
- $99.9 Billion
- Q1 2025
A detailed history of Rahlfs Capital, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Rahlfs Capital, LLC holds 5,325 shares of MRK stock, worth $405,019. This represents 0.48% of its overall portfolio holdings.
Number of Shares
5,325
Previous 5,325
-0.0%
Holding current value
$405,019
Previous $530 Million
9.77%
% of portfolio
0.48%
Previous 0.52%
Shares
1 transactions
Others Institutions Holding MRK
# of Institutions
3,888Shares Held
1.93BCall Options Held
26.2MPut Options Held
23.5M-
Vanguard Group Inc Valley Forge, PA253MShares$19.2 Billion0.42% of portfolio
-
Black Rock Inc. New York, NY207MShares$15.8 Billion0.59% of portfolio
-
State Street Corp Boston, MA121MShares$9.17 Billion0.46% of portfolio
-
Wellington Management Group LLP Boston, MA81.7MShares$6.21 Billion1.46% of portfolio
-
Geode Capital Management, LLC Boston, MA59.7MShares$4.54 Billion0.43% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $193B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...